MARISSA ADAMS: Open Payments
NPI 1972900033 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 56 payments from 14 companies in 2025. Trend: 2023 $983 · 2024 $835 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $236 |
| Merck Sharp & Dohme LLC | 10 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $112 |
| PFIZER INC. | 7 | $110 |
| Kestra Medical Technology Services, Inc. | 4 | $80 |
| Itamar Medical Inc | 1 | $72 |
| Stryker Corporation | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Alnylam Pharmaceuticals Inc. | 2 | $32 |
| Inari Medical, Inc. | 1 | $26 |
Products named: LEQVIO, VERQUVO, ELIQUIS, Kerendia, Assure WCD, WatchPATONE, FLOWTRIEVER CATHETER, S, AMVUTTRA.
Industry payments across LA — which companies pay providers there.
